Associated Papers
Adult genomic medicine: lessons from a multisite study of 2700 patients.
Bakur K et al.
Genome Medicine, 2025
Clinical and functional characterization of a novel TNFRSF9 variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis.
Zhao P et al.
Frontiers in Immunology, 2025
The unveiled face of IEI: Children Cancer Hospital-Egypt (CCHE-57357) experience.
Radwan N et al.
Frontiers in Immunology, 2025
Diagnostic implications of pitfalls in causal variant identification based on 4577 molecularly characterized families.
AlAbdi L et al.
Nature Communications, 2023
37644014 (PubMed )
Supplement: 41467_2023_40909_MOESM10_ESM.xlsx › Sheet1
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.
Shen K et al.
Clinical & Translational Immunology, 2023
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation.
Wildermann C et al.
Clinical Immunology (orlando, Fla.), 2021
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.
Alosaimi MF et al.
The Journal of Allergy and Clinical Immunology, 2019
Select a paper to view details